Investors anticipate “bounce-back” in European private investment
At the Swiss Biotech Day conference, panelists at an investment talk discussed the current state of the Swiss investment landscape.
Investment
Investors grapple with more choices in big year for pharma fundraising
Difficult biotech investment ecosystem forces focus on value
Signal: Dutch health investor Gilde raises $804m for health startup fund
BIO-Europe 2023: Pharma balances on shaky financial and legislative footing
M&A market performance suffered in Q3 2023
ADDF invest in BrainScope for Alzheimer’s prediction biomarker
Black Diamond Therapeutics to raise $75m from public offering
